DR J. DE WAN

Active

Private limited companyfounded 2006active for 20 yearsMaria-Joannalaan 40, 1640 Sint-Genesius-Rode, BelgiumKBO/BCE: BE 0881.826.406

Summary

DR J. DE WAN has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €491,989 and a net result of €33,331. Equity is growing by about 10% per year across the filed financial years. Its solvency ranks better than 87% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

DR J. DE WANActiveChecked score 95/100

Risk analysis Report Compare

Activity

Specialist medical practice

NACE 86220

4 sites

Size

€532,693total assets 2025

Equity: €491,989
Profit: €33,331

Turnover not published (micro format)

Financial health

95 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Structure

Accounts filed 48 days late0 of 2 deeds read

Why 95raises riskLatest accounts 48 days late; 3 of the last 3 latelowers riskLiquidity: current ratio 9.94, cash €329,958Sector: Human health activities (NACE 86)Equity €491,989 (92.4% of total assets)Show the evidence

Checked score

Score 2025

95 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 62% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 92.4% of total assets

Liquidity 100=

short-term debt 7.6% · cash 61.9%

Profitability 77-2

return on assets 6.3%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,112 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024highest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025lowest value 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €45,000 on 30-day terms is acceptable

Liquidity ample (current ratio 9.94, compared with 18.45 in 2024, above the usual 1.5; short-term debt: 7.6% and cash: 61.9% of total assets), and 7.6% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 21% on profitability and 49% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Liquidity: current ratio 9.94, cash €329,958

NBB · annual accounts

Sector: Human health activities (NACE 86)

KBO

Latest accounts 48 days late; 3 of the last 3 late

NBB · filings

Equity €491,989 (92.4% of total assets)

NBB · annual accounts

Filed after the deadline

The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 18-12-2025, 48 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 10 filings

Deviation from the deadline

2025

48 days late

2024

60 days late

2023

61 days late

2022

10 days late

2021

61 days late

2020

37 days late

2019

403 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 97 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 31-03-2026 is due by 31-10-2026. Nothing is late today. The company usually files around 30 December (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

31-03-2026 year end24-10-2026 today31-10-2026 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

18-12-2025 Annual accounts filedfinancial year 2025 · micro…
30-12-2024 Annual accounts filedfinancial year 2024 · micro…
31-12-2023 Annual accounts filedfinancial year 2023 · micro…

Key points

Positive: Among the best 13% on solvencysector median 63.0% · 20,598 companies 92.4% View
Total assets 20256 financial years filed €532,693 View
Active since 2006founded 13-06-2006 20 years View

By topic

Financials

Financial year: 2025
Total assets: €532,693
Profit: €33,331
Solvency: 92.4%

Total assets▲ 9.9%

Net result

20192025

Go to Financials

Timeline

Events: 22
Since: 2008
Next accounts: by 31-10-2026

31-03-2023Highest result from 2019 to 2025
10-11-2022Annual accounts filed
31-03-2022Back to profit

Go to Timeline

Company details

Sites: 4

Legal form: Private limited company
Activity: Specialist medical practiceNACE 86220
Founded: 13-06-2006
Year ends: 31-03
Peppol: Reachable for e-invoices

Go to Company details

Key facts about DR J. DE WAN

What is the company number of DR J. DE WAN?: 0881.826.406. In Belgium the VAT number is the company number with BE in front: BE 0881.826.406.
Where is DR J. DE WAN based?: The registered office is at Maria-Joannalaan 40, 1640 Sint-Genesius-Rode.Company details
What does DR J. DE WAN do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR J. DE WAN?: Private limited company (BV).
When was DR J. DE WAN founded?: On 13-06-2006.
Is DR J. DE WAN still active?: Yes, DR J. DE WAN is an active enterprise in the KBO register.
What is the turnover of DR J. DE WAN?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR J. DE WAN profitable?: In financial year 2025, DR J. DE WAN made a profit of €33,331.
Where can I find the annual accounts of DR J. DE WAN?: DR J. DE WAN filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR J. DE WAN due?: By 31-10-2026, for financial year 2026.Timeline